Mission Viejo, California, United States, Oct. 20, 2022 (GLOBE NEWSWIRE) — Leonhardt Ventures, LLC is happy to announce the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,471,686 masking bioelectric stimulation management of growing Klotho, a protein should recognized for muscle regeneration and different highly effective anti-aging properties. More than 3,000 papers have been printed describing a clear connection between low Klotho ranges and practically all age-related illnesses and main ailments, together with coronary heart and heart problems, muscle atrophy, kidney failure, most cancers, mind issues, hypertension and diabetes.
“This Klotho patent adds significant support to our goal mission to help people live longer and healthier lives. Adequate Klotho levels may be a critical factor in healthy aging and disease prevention. In landmark studies, mice deficient in Klotho exhibited accelerated aging and died 30% sooner than mice with normal Klotho levels. Mice receiving supplemental Klotho lived 30% longer with fewer aging-related ailments. In recent clinical studies, we have demonstrated up to a 150% increase in circulating Klotho with only two 45-minute bioelectric stimulation sessions a week for four weeks. We are conducting additional well controlled clinical studies to gather data to further demonstrate the safety and efficacy of this technology,” said Howard J. Leonhardt, Executive Chairman & CEO of Leonhardt Ventures, LLC.
This Klotho IP and know-how has been licensed for use with quite a few organ particular therapeutic candidate improvements, together with the next:
- Heart and Cardiovascular purposes embrace coronary heart, coronary heart valve, and aorta regeneration, and hypertension administration.
- Brain and Neurological purposes embrace remedies for despair, reminiscence loss, habit, spinal twine damage, stroke, and traumatic mind damage.
- Cosmetic and Personal Care purposes embrace pores and skin and hair regeneration, accelerated tooth straightening and stabilization, and remedy of sleep apnea and respiration issues, breast augmentation, and erectile dysfunction.
- Major Organ Regeneration purposes embrace muscle constructing and regeneration and coverings for bladder dysfunction, kidney failure, liver failure, lung restoration, covid restoration, imaginative and prescient and listening to restoration, and knee joint ache.
- Cancer Klotho has been proven in some pre-clinical research to exhibit tumor suppression exercise. Our portfolio startup CanceCell is growing Klotho stimulation and different bioelectric and biologic remedies for most cancers and has obtained 10 issued U.S. patents already.
The firm is growing KlothoYears, a program to offer entry to Klotho testing and schooling on methods to extend Klotho, and to offer contributors with a comparability of their degree to regular values for their age, gender, and different demographics. The program is in early beta launch analysis part in solely chosen areas at the moment and with plans in place to totally launch nationwide within the USA a while in 2023 with a examined full logistics system in place.
In 2021 Leonhardt Ventures LLC introduced it bought an unique license to mental property for KLOTHO EXPRESSING MESENCHYMAL STEM CELLS meant for use together with its bioelectric IP for a wide selection of longevity and wellness purposes. Our analysis crew believes this mixture represents the potential to be a potent remedy for sufferers most in want.
About Leonhardt Ventures LLC: Founded in 1982 by Howard J. Leonhardt, Leonhardt Ventures LLC (previously HJ Leonhardt & Co.) , situated in Mission Viejo, CA, is a enterprise creation lab, product invention growth laboratory, enterprise fund, and angel mentoring community. The Leonhardt crew launched the PolyCath TM line of cardiovascular balloon catheters within the Eighties, the TALENT TM (Taheri-Leonhardt) stent graft, StentValve, ProCell stem cell supply catheters, PENSIL intravascular lung, RadiCath electromagnetic radiation supply catheters, and bioelectric stimulators for bettering blood move within the Nineties. In 1987 Howard Leonhardt started a dialogue and collaboration with Dr. Robert. O. Becker Author of The Body Electric which influenced the ahead pathway of the corporate. Since then, the corporate has primarily targeted on the convergence of bioelectrics and biologics for longevity and wellness together with tissue organ restore and regeneration. In 1989 the crew working with Dr. Race Kao and Dr. George McGovern printed their first paper on coronary heart muscle regeneration with muscle stem cells (satellite tv for pc cells) in The Physiologist. In 1999 working with Dr. Shinichi Kanno the crew printed their first bioelectric regeneration paper in CIRCULATION. In 2001, the Leonhardt crew led the landmark first-ever non-surgical restore of a human coronary heart with muscle stem cells working with Dr. Doris Taylor, Dr. Warren Sherman and Dr. Patrick Serruys. In 2019 Leonhardt led a crew that accomplished the primary ever percutaneous aortic stent primarily based circulatory help pump placement working with Dr. Adrian Ebner. More than 600,000 sufferers have have been handled with Leonhardt medical gadget and biotechnology innovations since 1988. The Leonhardt crew has over 700 patent claims issued, pending, in course of, optioned or licensed. A partial itemizing is on the market at https://patents.justia.com/inventor/howard-j-leonhardt. Leonhardt’s Launchpads based in 2008 is the innovation and startup launch accelerator arm of Leonhardt Ventures LLC with an R&D lab at University Lab Partners at UCI Research Park, 5270 California Ave., Irvine, CA 92617. Leonhardt’s Launchpad’s portfolio of startups and improvements receives business mentoring and a selection of different assist companies from Cal-X Star Business Accelerator, Inc.
About Lionheart Health, Inc. : Lionheart Health, Inc. based in 2021 in beta launch part, is a gross sales, advertising and marketing, and distribution arm of Leonhardt Ventures LLC targeted on commercializing disruptive applied sciences for longevity and wellness. They plan to launch a number of merchandise within the U.S. and different markets starting in 2023. These embrace;
- BodStim™ is a bioelectric bodysuit that augments muscle constructing train and will increase Klotho
- SkinStim™ bioelectric pores and skin rejuvenation
- HairCell™ bioelectric hair rejuvenation
- ErectiStim™ by MyoStim ED bioelectric remedy for males’s sexual wellness.
The firm is working in partnership with established OEM producers with FDA 510(ok) market clearances for a number of indications, together with muscle stimulation, ache/irritation reduction, and circulation enchancment. The firm additionally intends to launch a chain of Longevity and Wellness MedSpas primarily based on its proprietary core applied sciences in 2024.
PUBLIC RELATIONS MEDIA CONTACT:
Brian Hardy
Leonhardt Ventures LLC
Tel: (424) 291-2133
Email: [email protected]
COMPANY CONTACT:
Howard J. Leonhardt
Executive Chairman and CEO
Email: [email protected]
Related Links:
Headquarters Office: Leonhardt Ventures LLC, 1 Kent Court, Mission Viejo, CA 92694
Main Web web site: www.leonhardtventures.com
Research and Development Lab
Leonhardt’s Launchpads
powered by Cal-X Stars Business Accelerator, Inc.
@ University Lab Partners UCI Research Park
5270 California Avenue
Irvine, CA 92617
For the unique information story, please go to https://www.prdistribution.com/news/u-s-patent-for-bioelectric-expression-of-klotho-a-key-longevity-and-disease-fighting-protein-issued-to-leonhardt-ventures/9355049
- U.S. Patent for Bioelectric Expression of Klotho, a Key Longevity and Disease-Fighting Protein Issued to Leonhardt Ventures
- U.S. Patent for Bioelectric Expression of Klotho, a Key Longevity and Disease-Fighting Protein Issued to Leonhardt Ventures
